Valuation: Molecure S.A.

Market Cap 127M 34M 29.46M 27.58M 25.17M 47.36M 3.24B 48.15M 323M 1.62B 128M 125M 5.41B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 95.81M 25.71M 22.28M 20.85M 19.03M 35.81M 2.45B 36.41M 245M 1.23B 96.52M 94.42M 4.09B EV / Sales 2025
19.2x
EV / Sales 2026 * 62.9x
Free-Float
70.71%
Yield 2025 *
-
Yield 2026 * -
1 day+0.65%
1 week+2.31%
Current month+1.31%
1 month+4.92%
3 months+14.63%
6 months-16.35%
Current year-6.21%
1 week 5.82
Extreme 5.82
6.23
1 month 5.6
Extreme 5.6
6.24
Current year 4.98
Extreme 4.98
9.04
1 year 4.98
Extreme 4.98
9.04
3 years 4.98
Extreme 4.98
25.5
5 years 4.98
Extreme 4.98
47.7
10 years 4.98
Extreme 4.98
80.4
Manager TitleAgeSince
Chief Executive Officer - 30/11/2012
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 02/01/2023
Director TitleAgeSince
Director/Board Member - 29/06/2021
Chairman 38 31/05/2023
Director/Board Member - 13/01/2022
Date Insider Type Main position Quantity % Market Cap.
22/12/23 Buy

Chief Executive Officer

49,000 0.2910%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%+2.31%-19.92%-70.52% 34M
-0.70%+13.34%+75.61%+103.83% 70.51B
-0.05%-0.05%+35.45%+63.68% 54.05B
-1.62%+34.25%+17.43%+491.04% 28.95B
-0.61%+12.51%+54.60%+7.40% 24.05B
0.00%+1.59%-15.06%-13.21% 23.31B
+9.77%+20.16%+260.17%+472.38% 18.67B
-0.36%+5.05%+43.61%-21.60% 18.37B
0.00%+7.46%+30.95%+623.97% 16.1B
-3.08%-8.34%+37.21%+138.52% 12.72B
Average +0.39%+356.62%+52.00%+179.55% 26.68B
Weighted average by Cap. +0.07%+350.10%+57.51%+168.98%

Financials

2025 2026 *
Net sales 3.9M 1.05M 907K 849K 775K 1.46M 99.8M 1.48M 9.95M 49.95M 3.93M 3.84M 167M 2M 537K 465K 435K 397K 747K 51.18M 760K 5.1M 25.62M 2.01M 1.97M 85.46M
Net income -21.2M -5.69M -4.93M -4.61M -4.21M -7.92M -543M -8.06M -54.11M -272M -21.36M -20.89M -906M -13M -3.49M -3.02M -2.83M -2.58M -4.86M -333M -4.94M -33.18M -167M -13.1M -12.81M -556M
Net Debt -30.9M -8.29M -7.18M -6.73M -6.14M -11.55M -791M -11.74M -78.87M -396M -31.13M -30.45M -1.32B -1M -268K -233K -218K -199K -374K -25.59M -380K -2.55M -12.81M -1.01M -985K -42.73M
Logo Molecure S.A.
Molecure SA, formerly known as Oncoarendi Therapeutics SA, is a Poland-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing therapeutics for neoplastic and inflammatory diseases. The Company's business model is focused on drug discovery and development, with its core strength in medicinal chemistry and preclinical biology, enhanced by scientific collaborations in specific disease areas. The Company has a platform of 3 distinct small molecule programs targeting chitinases hydrolytic enzymes with potential utility in diverse inflammatory and fibrotic diseases of high unmet medical need. Additionally, it has initiated a program focused on development of small molecule immune modulators to stop the ability of tumors to escape immune surveillance.
Employees
71
Date Price Change Volume
12/08/26 PLN 6.190 +0.65% 8,534
11/08/26 PLN 6.150 +1.32% 41,602
10/08/26 PLN 6.070 +0.33% 51,465
07/08/26 PLN 6.050 0.00% 40,173
06/08/26 PLN 6.050 0.00% 17,391
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.150PLN
Average target price
12.45PLN
Spread / Average Target
+102.44%

Quarterly revenue - Rate of surprise